Literature DB >> 16966147

Characterization of barrier properties and inducible VEGF expression of several types of retinal pigment epithelium in medium-term culture.

Pete Geisen1, Janet R McColm, Bradley M King, M Elizabeth Hartnett.   

Abstract

PURPOSE: To investigate and compare the characteristics of four different types of retinal pigment epithelium (RPE) cells cultured for 2 to 5 weeks to provide guidance when choosing RPE cells for experimentation.
METHODS: Human cell lines ARPE-19 (ARPE) and D407, primary RPE cells from C57Bl/6 mouse (mRPE), and primary human fetal RPE (hfRPE) cells were grown in respective media previously reported to be optimal for each cell type. Two methods to obtain hfRPE were used: one isolated outside and transported to our laboratory, and one isolated primarily within our laboratory from donor human fetal eyes. Barrier function was determined by transepithelial electrical resistance (TER) and permeability and structure by localization of Na+,K+-ATPase alpha-1, ZO-1, and actin. VEGF expression, determined by real-time polymerase chain reaction (PCR) for mRNA and ELISA for protein, was determined after exposure to 24 h of 1% oxygen. Madin-Darby canine kidney (MDCK) cells were compared as a non-RPE epithelial cell line.
RESULTS: ARPE at passage 15, but not passage 32, maintained steady low TER measurements (up to 30 ohms x cm(2)) despite forming a monolayer with apical Na+,K+-ATPase alpha-1 labeling after 35 days. mRPE developed and maintained a TER of 30 ohms x cm(2) for 2 weeks but did not localize ATPase. hfRPE showed two phenotypes. hfRPE isolated remotely and sent to us appeared more mesenchymal and undifferentiated (hfRPE-U) and had a slow but steady increase in measured TER to approximately 25 ohms x cm(2), whereas hfRPE isolated from donor eyes in our laboratory showed well-differentiated monolayers (hfRPE-D) with TER measurements > 500 ohms x cm(2) within 1 month of culture. TER measurements reflected permeability determined by the measurement of paracellular movement of sodium fluorescein. All human RPE cell types showed expression of VEGF mRNA and protein, and expression was upregulated by hypoxia in hfRPE and D407, but not in ARPE, which had constitutively high expression. ARPE expressed high levels of VEGF protein in media and cell lysates (777.2; 54.4 pg/mg protein, respectively), whereas hfRPE and D407 produced significantly less (media: 5.7 [p = 0.001], 323.6 pg/mg protein [p = 0.01]; lysate: 0 [p < 0.001], 3.5 pg/mg protein [p < 0.001], respectively).
CONCLUSIONS: Primary RPE cells and those from cell lines had different responses to medium-term culture or hypoxic stress. Primary isolation of hfRPE cells with careful control of culture conditions to assure adequate differentiation is recommended when using this cell as an example of a highly polarized epithelium. For disease, use of RPE cells that do not require long-term culture are more efficient and may be more relevant to study certain pathologies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16966147     DOI: 10.1080/02713680600837408

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  36 in total

1.  The role of vascular endothelial growth factor-induced activation of NADPH oxidase in choroidal endothelial cells and choroidal neovascularization.

Authors:  Elizabeth Monaghan-Benson; John Hartmann; Aleksandr E Vendrov; Steve Budd; Grace Byfield; Augustus Parker; Faisal Ahmad; Wei Huang; Marschall Runge; Keith Burridge; Nageswara Madamanchi; M Elizabeth Hartnett
Journal:  Am J Pathol       Date:  2010-08-27       Impact factor: 4.307

2.  A protocol for the culture and differentiation of highly polarized human retinal pigment epithelial cells.

Authors:  Shozo Sonoda; Christine Spee; Ernesto Barron; Stephen J Ryan; Ram Kannan; David R Hinton
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

3.  The small GTPase Rap1 is a novel regulator of RPE cell barrier function.

Authors:  Erika S Wittchen; M Elizabeth Hartnett
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-27       Impact factor: 4.799

4.  The role of Bcl-xL in mouse RPE cell survival.

Authors:  Sarah Medearis; Ian C Han; Jessica K Huang; Ping Yang; Glenn J Jaffe
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-17       Impact factor: 4.799

5.  A detailed three-step protocol for live imaging of intracellular traffic in polarized primary porcine RPE monolayers.

Authors:  Kimberly A Toops; Li Xuan Tan; Aparna Lakkaraju
Journal:  Exp Eye Res       Date:  2014-05-23       Impact factor: 3.467

6.  Antiapoptotic properties of α-crystallin-derived peptide chaperones and characterization of their uptake transporters in human RPE cells.

Authors:  Parameswaran G Sreekumar; Paresh Chothe; Krishna K Sharma; Rinku Baid; Uday Kompella; Christine Spee; Nandini Kannan; Christina Manh; Stephen J Ryan; Vadivel Ganapathy; Ram Kannan; David R Hinton
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-17       Impact factor: 4.799

7.  The effect of brimonidine on transepithelial resistance in a human retinal pigment epithelial cell line.

Authors:  Jung Hyun Park; Sung Joon Kim; Hyeong Gon Yu
Journal:  Korean J Ophthalmol       Date:  2010-06-05

8.  Attainment of polarity promotes growth factor secretion by retinal pigment epithelial cells: relevance to age-related macular degeneration.

Authors:  Shozo Sonoda; Parameswaran G Sreekumar; Satoru Kase; Christine Spee; Stephen J Ryan; Ram Kannan; David R Hinton
Journal:  Aging (Albany NY)       Date:  2009-12-27       Impact factor: 5.682

9.  CFH Y402H polymorphism and the complement activation product C5a: effects on NF-κB activation and inflammasome gene regulation.

Authors:  Sijia Cao; Jay Ching Chieh Wang; Jiangyuan Gao; Matthew Wong; Elliott To; Valerie A White; Jing Z Cui; Joanne A Matsubara
Journal:  Br J Ophthalmol       Date:  2016-01-08       Impact factor: 4.638

10.  Efflux protein expression in human retinal pigment epithelium cell lines.

Authors:  Eliisa Mannermaa; Kati-Sisko Vellonen; Tuomas Ryhänen; Katriina Kokkonen; Veli-Pekka Ranta; Kai Kaarniranta; Arto Urtti
Journal:  Pharm Res       Date:  2009-04-21       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.